Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Public Health, Environmental and Occupational Health,Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
Reference9 articles.
1. FDA. FDA Guidance for Industry: Changes to an Approved NDA or ANDA. Rockville, MD: Food and Drug Administration, CDER; 2004.
2. Wellek S. Testing Statistical Hypotheses of Equivalence and Noninferiority. 2nd ed. Boca Raton, FL: Chapman & Hall/CRC; 2010.
3. FDA. FDA Guidance for Industry: Dissolution Testing of Immediate Release Solid Oral Dosage Forms. Rockville, MD: Food and Drug Administration, CDER; 1997.
4. EMA. EMA Guidance on the Investigation of Bioequivalence. London: European Medicines Agency, CHMP; 2010.
5. Hoffelder T, Gössl R, Wellek S. Multivariate equivalence tests for use in pharmaceutical development. J Biopharm Stat. 2015;25(3):417–437.
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献